Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies
- 8 April 2009
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 18 (5), 454-463
- https://doi.org/10.1111/j.1600-0625.2008.00813.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- HLA class II haplotype DRB1*04–DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onsetPigment Cell Research, 2005
- CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseasesPigment Cell Research, 2005
- Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their FamiliesPigment Cell Research, 2003
- The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligoJCI Insight, 2002
- Mice lacking melanin-concentrating hormone are hypophagic and leanNature, 1998
- High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune VitiligoThe Journal of Experimental Medicine, 1998
- A role for melanin-concentrating hormone in the central regulation of feeding behaviourNature, 1996
- Clinical Variation of Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy (APECED) in a Series of 68 PatientsNew England Journal of Medicine, 1990
- Antibodies to normal human melanocytes in vitiligo.The Journal of Experimental Medicine, 1983
- Vitiligo in Graves' DiseaseAnnals of Internal Medicine, 1969